About GMFH Editing Team

GMFH Editing Team

Yava L. Jones-Hall, Ariangela Kozik and Cindy Nakatsu from Purdue University, West Lafayette, Indiana, USA, have recently published a paper in PLoS ONE on the role of Tumor Necrosis Factor (TNF) in Inflammatory Bowel Disease (IBD) and the impact of this pro-inflammatory cytokine on the gut microbiota.

Faecalibacterium prausnitzii is known for exhibiting anti-inflammatory effects in vitro and in vivo by secreted metabolites that block nuclear factor (NF)-κB activation. The low proportion of F. prausnitzii in the microbiome of Crohn’s disease patients characterizes the microbial dysbiosis associated with that condition.

Your microbiome is like a unique fingerprint

1 Jul 2015

by GMFH Editing Team

The more than 100 trillion microbes we host - the human microbiota - can identify us as individuals much like a fingerprint, a new study by Harvard TH Chan School of Public Health reveals.

In this interview, filmed during the 4th Gut Microbiota for Health World Summit, Professor Magnus Simrén of the University of Gothenburg (Sweden) and Chairman of the United European Gastroenterology (UEG) Scientific Committee, explains to Gut Microbiota Worldwatch the relationship between the gut microbiota and irritable bowel syndrome (IBS).

Here is a Storify selection of the best tweets gathered by Julien Tap who attended the recent EMBL Conference: The Human Microbiome, in Heidelberg, Germany, on June 10-12, 2015. ---- [View the story "EMBL Human Microbiome 2015" on Storify]

Two studies led by Spanish scientists from the Spanish National Research Council (CSIC) and published in the Nature group journals Scientific Report and ISME Journal, respectively, have, for the first time, quantified and classified the effects of some disorders on our gut microbiota based on studies of the substances produced by bacteria when decomposing food molecules, the metabolites.

Go to Top